Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...